H
Halo Pharma is a leading provider of pharmaceutical services, including contract dosage form development, commercial manufacturing, and analytical services. Halo is proudly part of the Normaco Group, joining Noramco and Purisys to provide customers with a complete North American-based supply chain solution covering clinical and commercial APIs through to clinical and commercial drug products.
Investor insights
Funding rounds participated in
$25M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Funding rounds raised
Total raised
$25M
from 1 investors over 1 rounds
H
Halo Pharmaceutical, Inc. raised $25M on April 10, 2025
Investors: Noramco